These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 18157

  • 1. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
    Bartsch W, Dietmann K, Leinert H, Sponer G.
    Arzneimittelforschung; 1977; 27(5):1022-6. PubMed ID: 18157
    [Abstract] [Full Text] [Related]

  • 2. [Comparative study on the effects of alprenolol, bunitrolol, ethaverine, oxprenolol, papaverine, practolol, pindolol, pronethalol, propranolol, toliprolol and verapamil on cardiac and bronchial beta-receptors (author's transl)].
    Wuppermann D, Zimmermann F, Friedrich L.
    Arzneimittelforschung; 1978; 28(5):794-8. PubMed ID: 35172
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z, Robak J, Kostka-Trabka E, Grodzińska L, Górka Z, Gryglewski R.
    Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
    [No Abstract] [Full Text] [Related]

  • 6. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
    Femmer K.
    Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
    Weber MA, Stokes GS, Gain JM.
    J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Effect of the beta-adrenergic blocking agent bupranolol on the plasma renin activity in normotensive rats].
    Placheta P, Singer E, Kraupp O.
    Arzneimittelforschung; 1977 Dec; 27(11):2063-6. PubMed ID: 23790
    [Abstract] [Full Text] [Related]

  • 11. [Study of minimal cardiac transit times in normal persons during beta-sympathicolysis (author's transl)].
    Freundlieb C, Höck A, Vyska K, Smolarz A, Feinendegen LE.
    Nuklearmedizin; 1979 Dec; 18(6):274-7. PubMed ID: 43966
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sympathomimetic and cardiodepressant effects of acebutolol, oxprenolol, pindolol, and propranolol. A comparative study on changes in hemodynamics, contractility, heart rate, and AV-conduction time at therapeutic doses.
    Gülker H, Kristek J, Heuer H, Bender F.
    Arzneimittelforschung; 1981 Dec; 31(9):1416-22. PubMed ID: 6118162
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Timolol maleate, a new beta-adrenergic receptor blocking agent.
    Hall RA, Robson RD, Share NN.
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):251-63. PubMed ID: 238479
    [Abstract] [Full Text] [Related]

  • 20. [Change of the reactibility of the myocardium following the termination of the beta-blocking effect of trimepranol and practolol].
    Svec P, Inczinger F, Béderová E, Zigová L.
    Cesk Farm; 1977 May; 26(4):128-30. PubMed ID: 880637
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.